Charles River Laboratories International, Inc.
Location
Massachusetts
Founded
1947-02-28
Website
Risk Signals
1069 news mentions monitored
Industry Context
This company is tracked across risk categories, including those related to its sector (e.g., Commercial Physical and Biological Research, Testing Laboratories), including supply chain integrity, ESG practices, labor disputes, and regulatory compliance.
Filter risk signals by topic
Select a theme below to explore the company’s news mentions in specific risk areas.
Recent Articles about Charles River Laboratories International, Inc.
Live alerts from global media, monitored by Business Radar
2022-06-13 (biopharma-reporter.com)
Charles River and ASC Therapeutics expand gene therapy manufacturing agreement
Charles River Laboratories International and ASC Therapeutics have announced plans to manufacture ASC618, a second-generation gene therapy for hemophilia A.
Read more2021-06-27 (milforddailynews.com)
Briefs on local businesspeople, including Bernadette M. Syppko, Eileen Potter, Tyler Bay and Kevin Schneider.
Movers & Shakers
Read more2021-06-20 (milforddailynews.com)
Briefs on local businesspeople, including James J. Dell'Anno, Tyler Bay, Kevin Schneider and Catrina M. Lopes.
Movers & Shakers
Read more
2018-09-04 (nature.com)
Expression and Manipulation of the APC-β-Catenin Pathway During Peripheral Neuron Regeneration
Molecules and pathways that suppress growth are expressed in postmitotic neurons, a potential advantage in mature neural networks, but a liability during regeneration. In this work, we probed the APC( adenomatous polyposis coli) -β-catenin partner pathway in adult peripheral sensory neurons during
Read more